
Our 2025 Roadmap goals
See our full 2025 roadmapSEEK NET POSITIVE IMPACT IN WELLNESS AND HEALTHCARE
Lay the foundation to evolve into a broader lifestyle, consumer wellness, and healthcare company in the long termKey performance indicators to track our progress
Lay the foundation to evolve into a broader lifestyle, consumer wellness, and healthcare company in the long term

See full performance metrics
view dataLearn more about PMI’s Sustainability Index in our Integrated Report 2024. See the full performance metrics and related footnotes here.
THE RIGHT THING TO DO
Researching and developing smoke-free alternatives that are scientifically substantiated to be less harmful than cigarettes was the first step in our journey to address our most significant negative externality: the impact of cigarette smoking on health.
Read moreTHE BUSINESS CASE
As described in our Statement of Purpose, with a longer horizon in sight, the critical element that completes PMI’s transformation is to think beyond a smoke-free future, and how our company can leverage the expertise and capabilities that we have accrued and developed and expand into adjacent avenues of growth, with offerings that go beyond tobacco and nicotine.
Read more
Our progress in 2024
Read more in our Integrated ReportLooking ahead
Michael Kunst, President, Aspeya
Our wellness and healthcare business strategy will continue to focus on developing and commercializing oral and inhaled consumer health and wellness offerings and inhaled prescription products for therapy areas such as pain management.
This includes medical and pharmaceutical cannabinoids, and non-recreational cannabinoid products (including CBD). By pursuing responsible innovation and the launch of products that are scientifically substantiated, we believe that we can find new and
better ways to improve lives.
This online content about our Integrated Report should be read in conjunction with PMI’s Integrated Report 2024. This report includes metrics that are subject to uncertainties due to inherent limitations in the nature and methods for data collection and measurement. The precision of different collection and measurement techniques may also vary. This report includes data or information obtained from external sources or third parties. Unless otherwise indicated, the data contained herein cover our operations worldwide for the full calendar year 2024 or reflect the status as of December 31, 2024. Where not specified, data comes from PMI financials, nonfinancials, or estimates.
Unless explicitly stated, the data, information, and aspirations in this report do not incorporate PMI’s wellness and healthcare business, Aspeya. Regarding the Swedish Match acquisition, completed late 2022, unless otherwise indicated, this report includes information pertaining to its sustainability performance. Please also refer to "This report at a glance" on page 2 of the PMI’s Integrated Report 2024 for more information. Aspirational targets and goals do not constitute financial projections, and achievement of future results is subject to risks, uncertainties and inaccurate assumptions, as outlined in our forward-looking and cautionary statements on page 206. In PMI’s Integrated Report 2024 and in related communications, the terms “materiality,” “material,” and similar terms are defined in the referenced sustainability standards and are not meant to correspond to the concept of materiality under the U.S. securities laws and/or disclosures required by the U.S. Securities and Exchange Commission.